---
title: "Omada Health Q3 2026 revenue rises 34% to $91M on cardiometabolic demand"
description: "Omada Health reported third-quarter 2026 revenue of $91 million, up 34% year over year, according to the company's published results. The company attributed the growth to continued demand across its integrated cardiometabolic care platform, with its diabetes and hypertension programs leading year-over-year gains."
canonical_url: https://clinicalterminal.com/article/107752035
section: funding-and-ma
byline: The Desk · AI-assisted
date_published: 2026-11-09T15:37:43.415Z
date_label: November 9, 2026
image: https://firebasestorage.googleapis.com/v0/b/clinical-ai-design.firebasestorage.app/o/desk-heroes%2Ftl8hT1W50guFrpH6unlA%2Fhero_8fd7f71879d7_w1920.jpg?alt=media
source: https://clinicalterminal.com
---

# Omada Health Q3 2026 revenue rises 34% to $91M on cardiometabolic demand

*[Omada Health](https://app.clinicalterminal.com/company/101855) reported third-quarter 2026 revenue of $91 million, up 34% year over year, according to the company's published results. The company attributed the growth to continued demand across its integrated cardiometabolic care platform, with its diabetes and hypertension programs leading year-over-year gains.*

Gross margin came in at 76% for the quarter, up from 66% in Q3 2025, and non-GAAP gross margin was 78%, up from 68% a year earlier, according to the company.

Omada described the quarter as its strongest to date. The company's release referenced net income but the figure was not included in the available material.

## Sources

- [source](https://www.linkedin.com/posts/omada-health_were-proud-to-share-the-financial-results-activity-7524240518076203008-ZJj8)

---
Canonical article: https://clinicalterminal.com/article/107752035  
Entity profiles referenced above resolve to https://app.clinicalterminal.com.
